The Continental landscape presents a shifting evolution in the perception of psychedelics. Historically stigmatized, these substances are now gain traction for their potential therapeutic applications. From Germany, where research are underway, to the UK, where awareness is growing, Europe is at the forefront in this re-evaluation of copyright cult